about
Bacillus anthracis edema factor substrate specificity: evidence for new modes of actionToxin-based therapeutic approachesCharacterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatmentAdded benefit of raxibacumab to antibiotic treatment of inhalational anthraxAnthrax vaccination strategiesRole of N-terminal His6-Tags in binding and efficient translocation of polypeptides into cells using anthrax protective antigen (PA)Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen.Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challengeNovel inhibitors of anthrax edema factor.Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections.Cryo-EM analysis of the organization of BclA and BxpB in the Bacillus anthracis exosporium.Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cellsProdrug applications for targeted cancer therapy.Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challengeEnhancing molecular flux through nanopores by means of attractive interactionsQuantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in miceAnthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunityToxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthraxSynthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamineRaxibacumab augments hemodynamic support and improves outcomes during shock with B. anthracis edema toxin alone or together with lethal toxin in canines.Inhibition of anthrax lethal factor: lability of hydroxamate as a chelating groupCutaneous anthrax in Lima, Peru: retrospective analysis of 71 cases, including four with a meningoencephalic complication.Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo.Phage-based platforms for the clinical detection of human bacterial pathogensAnthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signalingRecombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.Detoxified lethal toxin as a potential mucosal vaccine against anthrax.Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties.Role of aromatic amino acids in receptor binding activity and subunit assembly of the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans.Sizing the Bacillus anthracis PA63 channel with nonelectrolyte poly(ethylene glycols)Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human GlioblastomaThioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factorDynamics and energetics: a consensus analysis of the impact of calcium on EF-CaM protein complexEmerging themes of cAMP regulation of the pulmonary endothelial barrier.Anthrax lethal toxin and the induction of CD4 T cell immunity.Estimation of Time Period for Effective Human Inhalational Anthrax Treatment Including Antitoxin Therapy.Cell entry and cAMP imaging of anthrax edema toxin
P2860
Q27000357-B5DEFB49-8172-4515-A3AF-2946E9C3868EQ27013664-7E7043A3-BFD7-4E24-8C1E-667CB5CEAA29Q28387882-941173EE-0D1B-43C8-B8B6-F6FBD8F45342Q28388252-7AE2AFFE-8640-460A-86C1-EC0BBAB8EA6DQ28392248-FFA7533F-D70F-42DA-A53A-C61AB709A17AQ28484251-65BBD9F0-D37F-479F-A8FF-19D466C71E6AQ33224077-59B1D8CE-D5C0-4925-A3CF-EE95AEC64356Q33284583-F271EBBD-8984-478D-B85D-9BD50A1A2CBDQ33351165-10467660-8CF4-4A55-9302-C557EA4DAADFQ33715173-1E064682-4071-4EA9-990D-84A610B83550Q33852981-FE80CAC2-0040-48FD-901B-F8F4EEDC333CQ33995651-9063FC59-240F-40B3-9DE1-C483D208A81EQ34099780-C4A5C391-A16F-40A5-BAE0-30F1E93A584DQ34194628-DFFE3FE4-7DBD-4A74-A7ED-16B206818DFBQ34984331-AD2D7C27-E127-4CB7-8A88-33836DF7661AQ35077052-0966668F-9078-4C36-9A82-12DD20FD478CQ35085358-774F45B1-5A1D-4B4A-903B-F19700F6FE6AQ35161514-04001D3B-CF62-4D47-98EA-2BC3B22910A1Q35217494-A7053948-3258-4C01-BDC8-5C9A76FC5DBCQ35544367-8CAAEB2C-E5BE-49EC-962B-F345CAEE8021Q35759250-3A87A617-6191-4FDF-892E-83C5A25D144CQ35999716-A948C34C-3BCD-4AD4-8669-EAF6C1855A42Q36053697-DFC2663F-CA75-4055-AEF2-8E08E768BDD6Q36228556-71E31DEE-04D9-4177-85C7-06B4043EACCEQ36235362-33800CE6-A1E2-4BD1-95E2-8F43E70E82F0Q36403206-A259E913-D2BA-4B8B-AE53-0005AF6211B2Q36507229-431EFB64-7D4D-4690-BCFD-03E644E9F053Q36539063-EF3A3B8F-7B41-4CFA-B369-D50C591FD07FQ36586760-A7372511-8348-45E3-BDF4-DD83719DB539Q36690295-68857577-C23B-4CE9-844E-E691639A6EF0Q36747160-C713268E-982E-4F95-A479-10E9F738635CQ36783759-23A2C9AD-199D-4036-8B0A-559C262A21E0Q36884710-90230187-8CCF-4540-8175-F33591CD6C4EQ37156702-D2E189E4-5E47-4D45-81ED-D20E4379B1C5Q37231557-8E3A8D99-B11A-431D-B66F-01C0D828B784Q37279205-4CEA3C6C-CA61-4F9F-985E-E201989B743AQ37845025-44555FA1-65A7-4D6E-B97B-B09F63F816F3Q38060730-CB919105-46DD-4758-BF8C-A1634CEEC842Q38601348-093D77B4-45C7-4DD9-BEF9-C0656C627723Q39121575-408B3E2F-112E-45B0-AA34-431219F565CD
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anthrax toxin: a tripartite lethal combination.
@ast
Anthrax toxin: a tripartite lethal combination.
@en
Anthrax toxin: a tripartite lethal combination.
@nl
type
label
Anthrax toxin: a tripartite lethal combination.
@ast
Anthrax toxin: a tripartite lethal combination.
@en
Anthrax toxin: a tripartite lethal combination.
@nl
prefLabel
Anthrax toxin: a tripartite lethal combination.
@ast
Anthrax toxin: a tripartite lethal combination.
@en
Anthrax toxin: a tripartite lethal combination.
@nl
P2093
P2860
P50
P1433
P1476
Anthrax toxin: a tripartite lethal combination.
@en
P2093
Andrea Spallarossa
Cesare Montecucco
Paolo Ascenzi
P2860
P304
P356
10.1016/S0014-5793(02)03609-8
P407
P577
2002-11-01T00:00:00Z